BioCentury | Feb 28, 2005
Company News

Chiron management update

...Testing unit Hired: Daniel Soland as president of Chiron Vaccines, formerly president and CEO of Epigenesis Pharmaceuticals Inc....
BioCentury | Feb 24, 2005
Company News

Chiron names Goldstein COO

...hired Daniel Soland as president of Chiron Vaccines. Soland was previously president and CEO of Epigenesis...
BioCentury | Aug 11, 2003
Finance

Ebb & Flow

...$1-$2 million and average total investments per company of $3-$4 million. Its biotech portfolio includes Epigenesis...
BioCentury | Jun 16, 2003
Company News

EpiGenesis management update

EpiGenesis Pharmaceuticals Inc. , Cranbury, N.J. Business: Pulmonary Hired: Daniel Soland as president, CEO and a director, formerly VP and director of worldwide marketing operations for biologicals at GlaxoSmithKline plc WIR Staff Pulmonary...
BioCentury | Jun 16, 2003
Company News

EpiGenesis scientific advisory board update

EpiGenesis Pharmaceuticals Inc. , Cranbury, N.J. Business: Pulmonary Appointed: Jerry Karabelas, partner at Care Capital, as chairman; Reynold Panettieri, professor of medicine at the University of Pennsylvania; Sally Wenzel, professor of medicine at National Jewish Medical...
BioCentury | Jun 16, 2003
Company News

EpiGenesis board of directors update

EpiGenesis Pharmaceuticals Inc. , Cranbury, N.J. Business: Pulmonary Appointed: Jan Leschly, chairman and partner of Care Capital, as chairman; Liza Page Nelson, managing director and co-head of healthcare investing activities for Investor Growth Capital; Robert Mashal,...
BioCentury | Jun 9, 2003
Finance

Ebb & Flow

...the psychological barrier of the top end of the past year's trading range. Private rounds EpiGenesis...
...both gene expression-based drug discovery and drug development in cancer and respiratory diseases. Going forward, EpiGenesis...
...were centered on the discovery end of the value chain. Leonard estimates the funds give EpiGenesis...
BioCentury | Jun 9, 2003
Financial News

EpiGenesis raises $23 million

...Pulmonary company EpiGenesis (Princeton, N.J.) raised $23 million in a series A round led by Care...
...Investor Growth Capital; Boston Millennia Partners; Merrill Lynch Ventures; Technology Partners; and NJTC Venture Fund. EpiGenesis'...
BioCentury | Jan 28, 2002
Clinical News

EPI-2010: Phase II

...Chiesi Farmaceutica S.p.A. (Parma, Italy) has semi-exclusive rights in parts of Europe and South America. EpiGenesis Pharmaceuticals Inc....
BioCentury | Jul 30, 2001
Company News

EpiGenesis, Genta deal

...GNTA non-exclusively licensed several patents to EpiGenesis covering methods, compositions and processes for in vitro and...
...inhibition of protein synthesis by antisense oligonucleotides. GNTA will receive an upfront payment and royalties. EpiGenesis Pharmaceuticals Inc....
Items per page:
1 - 10 of 23
BioCentury | Feb 28, 2005
Company News

Chiron management update

...Testing unit Hired: Daniel Soland as president of Chiron Vaccines, formerly president and CEO of Epigenesis Pharmaceuticals Inc....
BioCentury | Feb 24, 2005
Company News

Chiron names Goldstein COO

...hired Daniel Soland as president of Chiron Vaccines. Soland was previously president and CEO of Epigenesis...
BioCentury | Aug 11, 2003
Finance

Ebb & Flow

...$1-$2 million and average total investments per company of $3-$4 million. Its biotech portfolio includes Epigenesis...
BioCentury | Jun 16, 2003
Company News

EpiGenesis management update

EpiGenesis Pharmaceuticals Inc. , Cranbury, N.J. Business: Pulmonary Hired: Daniel Soland as president, CEO and a director, formerly VP and director of worldwide marketing operations for biologicals at GlaxoSmithKline plc WIR Staff Pulmonary...
BioCentury | Jun 16, 2003
Company News

EpiGenesis scientific advisory board update

EpiGenesis Pharmaceuticals Inc. , Cranbury, N.J. Business: Pulmonary Appointed: Jerry Karabelas, partner at Care Capital, as chairman; Reynold Panettieri, professor of medicine at the University of Pennsylvania; Sally Wenzel, professor of medicine at National Jewish Medical...
BioCentury | Jun 16, 2003
Company News

EpiGenesis board of directors update

EpiGenesis Pharmaceuticals Inc. , Cranbury, N.J. Business: Pulmonary Appointed: Jan Leschly, chairman and partner of Care Capital, as chairman; Liza Page Nelson, managing director and co-head of healthcare investing activities for Investor Growth Capital; Robert Mashal,...
BioCentury | Jun 9, 2003
Finance

Ebb & Flow

...the psychological barrier of the top end of the past year's trading range. Private rounds EpiGenesis...
...both gene expression-based drug discovery and drug development in cancer and respiratory diseases. Going forward, EpiGenesis...
...were centered on the discovery end of the value chain. Leonard estimates the funds give EpiGenesis...
BioCentury | Jun 9, 2003
Financial News

EpiGenesis raises $23 million

...Pulmonary company EpiGenesis (Princeton, N.J.) raised $23 million in a series A round led by Care...
...Investor Growth Capital; Boston Millennia Partners; Merrill Lynch Ventures; Technology Partners; and NJTC Venture Fund. EpiGenesis'...
BioCentury | Jan 28, 2002
Clinical News

EPI-2010: Phase II

...Chiesi Farmaceutica S.p.A. (Parma, Italy) has semi-exclusive rights in parts of Europe and South America. EpiGenesis Pharmaceuticals Inc....
BioCentury | Jul 30, 2001
Company News

EpiGenesis, Genta deal

...GNTA non-exclusively licensed several patents to EpiGenesis covering methods, compositions and processes for in vitro and...
...inhibition of protein synthesis by antisense oligonucleotides. GNTA will receive an upfront payment and royalties. EpiGenesis Pharmaceuticals Inc....
Items per page:
1 - 10 of 23